Skip to main content
. Author manuscript; available in PMC: 2023 Dec 17.
Published in final edited form as: Ann Intern Med. 2015 Nov 24;163(12):899–907. doi: 10.7326/M15-0642

Figure 3. HCV viral load, by baseline HCV RNA level and RAV subgroup, in patients treated with ledipasvir and sofosbuvir plus GS-9451 with or without GS-9669.

Figure 3.

Vertical dashed lines indicate end of treatment. HCV = hepatitis C virus; LLOQ = lower limit of quantification; RAV = resistance-associated variant; SVR12 = HCV RNA level below LLOQ at posttreatment week 12.